Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-36.01	-212.29	331.75
Graham Fair Price	98.58	32.83	16.53
PEG	-94.76	0.03	-0.63
Price/Book	2.74	1.18	1.15
Price/Cash Flow	320.59	-29.15	6.93
Prices/Earnings	-76.80	12.94	55.77
Price/Sales	2.54	5.71	5.57
Price/FCF	320.59	-29.15	6.93
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.40	1.02	1.00
Operating Margin	-78.99	0.16	0.77
ROA	351.82	< 0.005	< 0.005
ROE	< 0.005	0.02	342.79
ROIC	0.04	0.01	-68.20
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.27	-0.10	-170.24
Dividends QOQ	0.05	-0.05	-4.93
EBIT QOQ	2.12	-0.80	-62.25
EPS QOQ	-0.89	3.95	342.88
FCF QOQ	5.89	-1.23	-79.12
Revenue QOQ	0.47	-0.05	-88.67
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	17784.00	100.00
Days Sales Outstanding (DSO)	544.29	57.10	-89.51
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.60	0.54	-10.49
Quick Ratio	0.59	0.57	-4.17
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	48.57	45.83	-5.63
Cash	81.05	105.66	30.35
Capex	-0.45	-0.30	33.38
Free Cash Flow	8.05	-1.86	-76.95
Revenue	10.02	9.47	-5.45
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.32	0.23	-28.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.70	-46.19	294.90
Naive Interpretation	Member

06 - Financial Health · Bad

Rating